Global leishmaniasis surveillance: 2019-2020, a baseline for the 2030 roadmap
Date of Publication
2021 12:00 AM
Security Theme
Health
Keywords
Health Security, health, world health, leishmaniasis, Americas, East Africa, North Africa, West Asia, South East Asia
Description
Leishmaniasis continues to be a major health problem in 4 eco-epidemiological regions of the world: the Americas, East Africa, North Africa and West and South East Asia. There are 4 main forms of the disease: visceral leishmaniasis (VL, also known as kala-azar), post-kala-azar dermal leishmaniasis (PKDL), cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis. While CL is the most common form of the disease, VL is the most serious and is almost always fatal if untreated. This update follows those of data up to 2016 and 2018. Six indicators of leishmaniasis are publicly available through the Global Health Observatory (GHO). In addition to the GHO, country profiles with a total of 30 indicators are published, with detailed data received from 43 Member States.
Global leishmaniasis surveillance: 2019-2020, a baseline for the 2030 roadmap
Leishmaniasis continues to be a major health problem in 4 eco-epidemiological regions of the world: the Americas, East Africa, North Africa and West and South East Asia. There are 4 main forms of the disease: visceral leishmaniasis (VL, also known as kala-azar), post-kala-azar dermal leishmaniasis (PKDL), cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis. While CL is the most common form of the disease, VL is the most serious and is almost always fatal if untreated. This update follows those of data up to 2016 and 2018. Six indicators of leishmaniasis are publicly available through the Global Health Observatory (GHO). In addition to the GHO, country profiles with a total of 30 indicators are published, with detailed data received from 43 Member States.
